Robbins LLP is Investigating Allegations that Varonis Systems, Inc. (VRNS) Misled Investors Regarding its Business Prospects

Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Varonis Systems, Inc. (NASDAQ: VRNS) securities between February 5, 2025 and October 28, 2025. Varonis is a global security company that provides software products and services to discovery and classify critical data, remediate exposures, and detect advanced threats with the help of AI-powered technologies.

The Allegations:

According to the complaint, defendants created the false impression that they possessed reliable information pertaining to the Company’s projected revenue outlook and anticipated growth while also minimizing risk from seasonality and macroeconomic fluctuations. In truth, Varonis’ optimistic reports of growth, cost cutting measures, and overall effectiveness of its sales team to continue to convince existing clientele to convert to the SaaS offering fell short of reality. In fact, Varonis was ill-equipped to continue its annual recurring revenue growth trajectory without maintaining a significantly high rate of quarterly conversion.

Plaintiff alleges that on October 28, 2025, defendants released third quarter results below prior projections and lowered their full-year guidance. On this news, the price of Varonis’ common stock declined from $63.00 per share on October 28, 2025, to $32.34 per share on October 29, 2025, a decline of about 48.67% in the span of just a single day.

What Now: You may be eligible to participate in the class action against Varonis Systems, Inc. Shareholders who wish to serve as lead plaintiff for the class must submit their papers to the court by March 9, 2026. The lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation.  You do not have to participate in the case to be eligible for a recovery. If you choose to take no action, you can remain an absent class member.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.